{"id":"W4385667424","doi":"10.1097/01.hs9.0000969628.70235.a8","title":"P681: MATCHING-ADJUSTED INDIRECT COMPARISON OF ASCIMINIB VERSUS OTHER TYROSINE KINASE INHIBITORS IN THIRD-OR-LATER LINE CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Bosutinib; Medicine; Dasatinib; Nilotinib; Ponatinib; Internal medicine; Oncology; Population; Myeloid leukemia; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01281234,0.002129239,0.002739997,0.0009013798,0.000368522,0.001150891,0.001573795,0.001437694,0.01001574],"category_scores_gemma":[0.02586679,0.000482733,0.008044801,0.0009687828,0.0008309999,0.001183264,0.001743152,0.002447386,0.0005305252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001231238,"about_ca_system_score_gemma":0.001021392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002059292,"about_ca_topic_score_gemma":0.001435971,"domain_scores_codex":[0.9837046,0.01286347,0.0007638952,0.001245966,0.000877028,0.0005450799],"domain_scores_gemma":[0.9893534,0.007322569,0.001758178,0.0008496877,0.0003884561,0.0003276377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7683846,0.00260644,0.02945592,0.005903703,0.1070274,0.0001837134,0.0003602089,0.01375822,0.002077823,0.00354609,0.003096133,0.06359973],"study_design_scores_gemma":[0.270333,0.288535,0.1601536,0.001295462,0.1697173,0.0006920713,0.0008120563,0.06209327,0.008666305,0.0201933,0.01710428,0.0004045048],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9662104,0.007689509,0.01055722,0.0005972161,0.0009889124,0.003198828,0.005950316,0.0001760617,0.004631385],"genre_scores_gemma":[0.9889539,0.0005632447,0.004734764,0.0003443797,0.0001104706,0.002599215,0.001403752,0.000021154,0.001268958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01281234,"threshold_uncertainty_score":0.06775898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05732872494174309,"score_gpt":0.3475958001907948,"score_spread":0.2902670752490517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}